Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIVANTAMAB-VMJW vs AMLODIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMIVANTAMAB-VMJW vs AMLODIPINE: Safety Overview

Metric AMIVANTAMAB-VMJW AMLODIPINE
Total FAERS Reports 2,005 64,924
Deaths Reported 159 10,161
Death Rate 7.9% 15.7%
Hospitalizations 362 26,787
Average Patient Age 66.0 yrs 62.8 yrs
% Female Patients 64.4% 57.0%
FDA Approval Date N/A Apr 12, 2011
Manufacturer N/A Teva Pharmaceuticals USA, Inc.
Route N/A ORAL
Marketing Status Prescription Prescription